Livmoniplimab, Budigalimab
M19-345
Phase 1 small_molecule active
Quick answer
Livmoniplimab, Budigalimab for Locally Advanced or Metastatic Solid Tumors, Solid Tumors is a Phase 1 program (small_molecule) at AbbVie Deutschland GmbH & Co. KG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AbbVie Deutschland GmbH & Co. KG
- Indication
- Locally Advanced or Metastatic Solid Tumors, Solid Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active